GyrA/B fluoroquinolone resistance allele profiles amongst Mycobacterium tuberculosis isolates from mainland China

International Journal of Antimicrobial Agents

Volumn 39, Issue 6, 2012, Pages 486-489

  Long, Quanxin ^a   Li, Weimin ^b   Du, Qinglin ^a   Fu, Yuhong ^b   Liang, Qian ^b   Huang, Hairong ^b   Xie, Jianping ^a  

^a SOUTHWEST UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Fluoroquinolone resistance; Mainland China; Molecular resistance mechanism; Mycobacterium tuberculosis

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING) A; DNA TOPOISOMERASE (ATP HYDROLYSING) B; LEVOFLOXACIN; OFLOXACIN;

ANTIBIOTIC RESISTANCE; BACTERIAL GENE; BACTERIUM ISOLATE; CHINA; CONFERENCE PAPER; GENE MUTATION; GENETIC RESISTANCE; GYRA GENE; GYRB GENE; MATHEMATICAL ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

ALLELES; CHINA; DNA GYRASE; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; OFLOXACIN; TUBERCULOSIS;

EID: 84860470151     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2012.02.015     Document Type: Conference Paper

References (30)

1. World Health Organization Guidelines for the programmatic management of drug-resistant tuberculosis 2006 WHO Geneva, Switzerland
2. H.M. Blumberg, W.J. Burman, R.E. Chaisson, C.L. Daley, S.C. Etkind, and L.N. Friedman American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis Am J Respir Crit Care Med 167 2003 603 662
3. E.L. Nuermberger, T. Yoshimatsu, S. Tyagi, K. Williams, I. Rosenthal, and R.J. O'Brien Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosis Am J Respir Crit Care Med 170 2004 1131 1134 (Pubitemid 39488628)
4. R. Rustomjee, C. Lienhardt, T. Kanyok, G.R. Davies, J. Levin, and T. Mthiyane A phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis Int J Tuberc Lung Dis 12 2008 128 138 (Pubitemid 351212403)
5. A.S. Ginsburg, J.H. Grosset, and W.R. Bishai Fluoroquinolones, tuberculosis, and resistance Lancet Infect Dis 3 2003 432 442 (Pubitemid 36791119)
6. K. Drlica, and X. Zhao DNA gyrase, topoisomerase IV, and the 4-quinolones Microbiol Mol Biol Rev 61 1997 377 392 (Pubitemid 28090230)
7. L.M. Wentzell, and A. Maxwell The complex of DNA gyrase and quinolone drugs on DNA forms a barrier to the T7 DNA polymerase replication complex J Mol Biol 304 2000 779 791 (Pubitemid 32047082)
8. K. Drlica, H. Hiasa, R. Kerns, M. Malik, A. Mustaev, and X. Zhao Quinolones: action and resistance updated Curr Top Med Chem 9 2009 981 998
9. A. Von Groll, A. Martin, P. Jureen, S. Hoffner, P. Vandamme, and F. Portaels Fluoroquinolone resistance in Mycobacterium tuberculosis and mutations in gyrA and gyrB Antimicrob Agents Chemother 53 2009 4498 4500
10. H.E. Takiff, L. Salazar, C. Guerrero, W. Philipp, W.M. Huang, and B. Kreiswirth Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations Antimicrob Agents Chemother 38 1994 773 780 (Pubitemid 24114017)
11. R.C.Y. Chan, M. Hui, E.W.C. Chan, T.K. Au, M.L. Chin, and C.K. Yip Genetic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates in Hong Kong J Antimicrob Chemother 59 2007 866 873 (Pubitemid 47078721)
12. T.S. Huang Trends in fluoroquinolone resistance of Mycobacterium tuberculosis complex in a Taiwanese medical centre: 1995-2003 J Antimicrob Chemother 56 2005 1058 1062
13. I. Mokrousov, T. Otten, O. Manicheva, Y. Potapova, B. Vishnevsky, and O. Narvskaya Molecular characterization of ofloxacin-resistant Mycobacterium tuberculosis strains from Russia Antimicrob Agents Chemother 52 2008 2937 2939
14. D.D. An, N.T. Hong Duyen, N.T.N. Lan, D.V. Hoa, D.T.M. Ha, and V.S. Kiet Beijing genotype of Mycobacterium tuberculosis is significantly associated with high-level fluoroquinolone resistance in Vietnam Antimicrob Agents Chemother 53 2009 4835 4839
15. A.N. Umubyeyi, L. Rigouts, I.C. Shamputa, K. Fissette, Y. Elkrim, and P.W.B. de Rijk Limited fluoroquinolone resistance among Mycobacterium tuberculosis isolates from Rwanda: results of a national survey J Antimicrob Chemother 59 2007 1031 1033 (Pubitemid 47073381)
16. World Health Organization. Guidelines for drug susceptibility testing for second-line anti-tuberculosis drugs for DOTS-Plus. Geneva, Switzerland: WHO; 2001. WHO/CDS/TB/2001.288. http://whqlibdoc.who.int/hq/2001/WHO-CDS-TB-2001.288. pdf [accessed 12 March 2012].
17. W.K. Aldous, J.I. Pounder, J.L. Cloud, and G.L. Woods Comparison of six methods of extracting Mycobacterium tuberculosis DNA from processed sputum for testing by quantitative real-time PCR J Clin Microbiol 43 2005 2471 2473 (Pubitemid 40656270)
18. X. Yin, and Z. Yu Mutation characterization of gyrA and gyrB genes in levofloxacin-resistant Mycobacterium tuberculosis clinical isolates from Guangdong Province in China J Infect 61 2010 150 154
19. Z. Cui, J. Wang, J. Lu, X. Huang, and Z. Hu Association of mutation patterns in gyrA/B genes and ofloxacin resistance levels in Mycobacterium tuberculosis isolates from East China in 2009 BMC Infect Dis 11 2011 78
20. P. Pitaksajjakul, W. Wongwit, W. Punprasit, B. Eampokalap, S. Peacock, and P. Ramasoota Mutations in the gyrA and gyrB genes of fluoroquinolone- resistant Mycobacterium tuberculosis from TB patients in Thailand Southeast Asian J Trop Med Public Health 36 Suppl. 4 2005 228 237
21. N. Siddiqi, M. Shamim, S. Hussain, R.K. Choudhary, N. Ahmed, and Prachee Molecular characterization of multidrug-resistant isolates of Mycobacterium tuberculosis from patients in north India Antimicrob Agents Chemother 46 2002 443 450 (Pubitemid 34087194)
22. I. Escribano, J.C. Rodríguez, B. Llorca, E. García-Pachon, M. Ruiz, and G. Royo Importance of the efflux pump systems in the resistance of Mycobacterium tuberculosis to fluoroquinolones and linezolid Chemotherapy 53 2007 397 401 (Pubitemid 350085252)
23. K. Drlica, M. Malik, R.J. Kerns, and X. Zhao Quinolone-mediated bacterial death Antimicrob Agents Chemother 52 2007 385 392 (Pubitemid 351170804)
24. S. Feuerriegel, H.S. Cox, N. Zarkua, H.A. Karimovich, K. Braker, and S. Rusch-Gerdes Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatment Antimicrob Agents Chemother 53 2009 3353 3356
25. I. Comas, S. Homolka, S. Niemann, and S. Gagneux Genotyping of genetically monomorphic bacteria: DNA sequencing in Mycobacterium tuberculosis highlights the limitations of current methodologies PLoS One 4 2009 e7815
26. D.E. Rozen, L. McGee, B.R. Levin, and K.P. Klugman Fitness costs of fluoroquinolone resistance in Streptococcus pneumoniae Antimicrob Agents Chemother 51 2006 412 416
27. J. Ruiz, A. Moreno, M.T. Jimenez de Anta, and J. Vila A double mutation in the gyrA gene is necessary to produce high levels of resistance to moxifloxacin in Campylobacter spp. clinical isolates Int J Antimicrob Agents 25 2005 542 545 (Pubitemid 40732611)
28. N. Mor, J. Vanderkolk, and L. Heifets Inhibitory and bactericidal activities of levofloxacin against Mycobacterium tuberculosis in vitro and in human macrophages Antimicrob Agents Chemother 38 1994 1161 1164 (Pubitemid 24150857)
29. W.W. Yew Comparative roles of levofloxacin and ofloxacin in the treatment of multidrug-resistant tuberculosis: preliminary results of a retrospective study from Hong Kong Chest 124 2003 1476 1481 (Pubitemid 37290060)
30. M.L. Wilson Recent advances in the laboratory detection of Mycobacterium tuberculosis complex and drug resistance Clin Infect Dis 52 2011 1350 1355